Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Carol F. Farver, MD, is a Staff pathologist in the Department of Anatomic Pathology at Cleveland Clinic's main campus. She joined Cleveland Clinic in 1995 and also holds joint appointments for Cleveland Clinic’s Transplantation Center, and Departments of Pulmonary and Critical Care Medicine, Pathobiology and Education Division.
In addition to her medical degree from Yale University, she has two master’s degrees and attended the doctoral program at University of California at Berkeley. Dr. Farver served as chief resident at Brigham and Woman’s Hospital, Boston, and went on to be a clinical and research fellow as well as instructor at Harvard Medical School. She is now Assistant Clinical Professor of Medicine at Case Western Reserve University. She is licensed to practice medicine in both Ohio and Massachusetts, and is board-certified in anatomic pathology.
She has participated either as lead author or co-author in dozens of peer-reviewed journal articles and abstracts with her major research interests including cytokine control of lung injury, prognostic indicators of lung cancer and biology/pathology of lung transplantation. She is also a renowned speaker for educational and scientific sessions.
Dr. Farver has received the Cleveland Clinic’s Word Class Service Leadership Development Award, and the Innovator Award for a ‘Dual Frequency Ventilation' project. She is past president of the Cleveland Society of Pathologists, and current member of the American Society for Investigative Pathology, United States and Canadian Academy of Pathology, American Thoracic Society, American Society of Clinical Pathologists, Ohio Society of Pathologists and New England Society of Pathologists.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/2/2014, Dr. Farver has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.